The Utah Legislature has approved a bill that would allow naturopathic physicians to prescribe transdermal or buccal testosterone (but not injectable esters of testosterone). The “Hormone Restoration Amendments” (HB-108) passed the Utah Senate on March 9, 2009 and the Utah House on February 10, 2009. Placing the risks of testosterone in perspective, Rep. Paul Ray stated, “I’ve been married 17 years and too much estrogen scares me a heck of a lot more than testosterone.” Utah will become the fifth state to grant prescriptive rights for testosterone to naturopathic physicians when the bill is signed by Gov. Jon Huntsman. Utah joins Arizona, Oregon, Vermont, and Washington as the only other states where naturopathic physicians can prescribe testosterone (”Bill will allow naturopathic doctors to prescribe testosterone,” March 5, 2009).
The “Hormone Restoration Amendments” were opposed by the Utah Medical Association and the Utah Health System Pharmacy who expressed their antagonism towards compounding pharmacies during debates. The Utah Health Insurance Association was also concerned that the bill would force insurance companies to cover naturopathic physician-prescribed testosterone replacement therapy (TRT).
The Utah Association of Naturopathic Physicians was well-informed and knowledgeable regarding testosterone and federal steroid laws. The representatives for the Utah Medical Association and the Utah Health System Pharmacy were not; their testimony was inaccurate and misleading with respect to steroid law and steroid side effects. The UMA sent a non-medical expert to present their case opposing the bill. Read more
The pharmaceutical giant Solvay Pharmaceuticals is unapologetic about its actions aimed at maintaining its monopoly on the phamaceutical testosterone gel Androgel (an anabolic-androgenic steroid). Solvay has “bought off” generic companies who planned to introduce inexpensive, generic versions of Androgel. The generic companies Watson Pharmaceuticals, Par Pharmaceutical, and Paddock Laboratories were prepared to offer a cheap generic testosterone gel as early as 2006 after the FDA granted Watson final approval for its generic product in January 2006. Solvay paid the generic companies a substantial amount of money to delay their entry into the generic Androgel marketplace until 2015.
The threat of generic competition would have decimated Solvay’s sales of Androgel; AndroGel has been their top-selling product with sales exceeding $300 million in 2006 and $400 million in 2007. Generic competition to Solvay’s flagship product Androgel could reduce the price of testosterone gel as much as 90% when compared to brand name Androgel. The payments to delay entry into the generic marketplace aka “pay-for-delay” settlements would be highly profitable for Solvay by extending brand name patent protection for several years. The windfall profits would come at the expense of consumers and federal taxpayers costing them billions of dollars Read more
The Los Angeles Police Department discovered former bodybuilding cosmetic surgeon Bruce Nadler, MD and his wife dead as the result of gunshot wounds on Monday, February 4, 2008. Authorities believe it is an apparent murder-suicide perpetrated by Bruce Nadler.
Bruce Nadler called himself the “world’s strongest plastic surgeon.” He was probably the best known cosmetic surgeon catering to amateur and professional bodybuilders. He had performed over 700 gynecomastia surgeries in his career; “gyno” is a side effect of anabolic steroid use when antiaromatase and/or estrogen antagonists are not use concurrently.
After retiring from the practice of medicine in August 2005, Dr. Nadler, who called himself “the world’s strongest plastic surgeon,” wrote the “The Nip Tuck Workout: Exercise through the Eyes of a Plastic Surgeon” and subsequently moved with his wife to Los Angeles to reinvent himself in a new career as personal trainer with the opening of Nip Tuck Fitness LA in Beverly Hills.
Retired plastic surgeon and certified personal trainer Bruce J. Nadler M.D. has brought his Plastic Synergy training system to Los Angeles. As stated in his book, “The Nip Tuck Workout – Exercise through the Eyes of a Plastic Surgeon,” Dr. Nadler has created an exercise program based on the plastic surgical principles of proportion and symmetry. It combines careful analysis with an individualized exercise prescription.
Bruce Nadler, MD retired after the New York State Board of Professional Medical Conduct charged him with 29 specifications of professional misconduct in thirteen patients according to public records. Rather than fight the charges, Nadler submitted and consent agreement and voluntarily relinquished his medical license.
The specifications of professional misconduct were primarily related to prescribing a variety of anabolic steroids, growth hormone and ancillary medications used by bodybuilders including Saizen, Serostim, Genotropin, Androgel, Depo Testosterone, Delatestryl, Deca Durabolin, testosterone cypionate, testosterone enanthate, Nolvadex, Proscar, Clomid, tamoxifen, Arimidex, Finasteride and Viagra. In each case, he was accused of the following:
-
Failure to obtain and/or note an adequate and complete medical history and/or history of current complaint from patient.
-
Failure to perform and/or note a complete and appropriate physical examination of patient.
-
Failure to obtain and/or note appropriate and medically indicated laboratory studies on patient including: prolactin, TSH, LH, hepatic and renal function, and assays for estrogen levels and HCG.
-
Failure to properly diagnose patient’s condition and/or rule out underlying disorders.
-
Inappropriately and without medical idnication and/or justification, prescribing and/or maintaining patient on various medications.
-
Failure to maintain a medical record for patient in accordance with accepted medical standards which accurately reflects his care and treatment of the patient.
Bruce Nadler’s beliefs regarding anabolic steroids and bodybuilding were controversial for physician. He explained his own steroid use and his willingness to prescribe steroids and growth hormone to his patients in an interview with Testosterone Nation:
I’m my own test laboratory in that respect because, in the last two years, I’ve been taking 6 to 8 IUs a week of growth hormone, and I alternate between 200 mg a week of deca and 200 mg of testosterone cypionate the next week. Instead of going super physiological, I believe in just going to maximum natural levels to that of a man in his twenties. In this way, there are no side effects.
Nadler was also critical of the steroid hysteria in the U.S. and the political posturing surrounding anabolic steroids:
I’ve always felt that politicians always have to make the majority of the electorate think that they’re doing something? So they inconvenience a small, unimportant group, like bodybuilders. They have no idea what they’re talking about. Somebody hands them a speech, and they go! They took something that could have been done safely and sent it to the black market and all of the inherent dangers that go along with dealing with that element. Will they ever be legal again? I hope so.
Could you imagine a pharmaceutical company (whose top-selling drugs are anabolic steroids) becoming the title sponsor of a professional bodybuilding contest? What is Unimed, whose top selling drug products are Anadrol-50 (oxymetholone) and AndroGel (testosterone), sponsored the Mr. Olympia Bodybuilding contest resulting in the “Unimed Pharmaceuticals IFBB Mr. Olympia Bodybuilding Championships”?!! Or how about Savient, whose top-selling drug product is Oxandrin (oxandrolone), sponsoring the Arnold Classic resulting in the Savient Pharmaceuticals IFBB Arnold Schwarzenegger Classic Bodybuilding Championships?!! Observers would comment on the irony given that professional bodybuilding is practically synonymous with the use of anabolic steroids.
Interestingly, in the sport of professional cycling, such an unlikely sponsorship has been taking place since 2006 when the biotechnology company Amgen became the title sponsor of professional cycling’s Amgen Tour of California. One prominent cycling commentator called it the “death of irony.” You see, Amgen’s most successful product to date is Epogen (recombinant erythropoietin); it’s second best-selling drug is a long-acting version of Epogen called Aranesp (darbepoietin). Epogen is the most notorious performance-enhancing drug in cycling; Epogen is to professional cycling what anabolic steroids are to professional bodybuilding!
If the controversial title sponsorship was not enough, Tour of California organizers accidentally forgot to drug test riders for Epogen during the inaugural 2006 Amgen Tour of California. They tested for all other banned drugs but simply forgot to test for Epogen!
And why is Amgen spending $35 million sponsorship over a 5-year commitment on professional cycling? Is it because professional cyclist represent proof of the miraculous performance-enhancing effects of their products? Not exactly. Amgen’s scientific director Dr. Steven Elliott explains:
Our opportunity is to educate cyclists that there is an appropriate way to use a drug, and doping in sport is not it… Our medicines were made because we want to treat grievous illnesses. They’re not for enhancing performance in sport.
I think the sport of professional bodybuilding could use a $35 million infusion by a giant pharmaceutical company who manufacturers anabolic steroids and/or human growth hormone who could use the sponsorship as an opportunity to promote the therapeutic benefits of anabolic steroids and other performance-enhancing drugs.
But then again, along with the Amgen sponsorship of the Tour of California came pressure to expand anti-doping testing and improve anti-doping procedures.
The upcoming 2008 Amgen Tour of California cycling road race will adopt the most comprehensive anti-doping protocol in cycling history it was announced by Andrew Messick, president, AEG Sports, presenter of the race, at a press conference today.
This is something that professional bodybuilding probably does not want.
